HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 316 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $345,252 | +18.0% | 9,038 | +11.4% | 0.07% | -12.9% |
| Q2 2023 | $292,600 | +114.4% | 8,112 | +127.0% | 0.08% | +93.2% |
| Q1 2023 | $136,491 | -39.5% | 3,574 | -9.9% | 0.04% | -41.3% |
| Q4 2022 | $225,665 | +35.1% | 3,966 | -6.2% | 0.08% | -8.5% |
| Q3 2022 | $167,000 | -13.9% | 4,226 | -4.1% | 0.08% | -31.7% |
| Q2 2022 | $194,000 | -41.0% | 4,407 | -46.6% | 0.12% | -27.3% |
| Q1 2022 | $329,000 | -20.7% | 8,256 | -20.0% | 0.16% | -14.5% |
| Q4 2021 | $415,000 | +24.3% | 10,321 | +25.6% | 0.19% | -10.2% |
| Q3 2021 | $334,000 | +18.4% | 8,215 | +32.5% | 0.22% | +20.8% |
| Q2 2021 | $282,000 | – | 6,200 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |